Results 211 to 220 of about 2,408,243 (341)

Structured Medication Review and Shared Decision-Making in Patients with Mild Intellectual Disabilities Who Use Psychotropic Medication. [PDF]

Pharmacy (Basel)
de Kuijper G, Jonker J, Hoge R.
europepmc   +1 more source

Self-medication among health sciences´ students

, 2021
Aleksandar Cvetković-Vega, Flor Chumachero-Zegarro, Max Benites-Aguirre   +2 more
openalex   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Development and Psychometric Validation of the Hospital Medication System Safety Assessment Questionnaire. [PDF]

Nurs Rep
Sales L, Cardoso AF, Araújo B, Jesus É.   +3 more
europepmc   +1 more source

Enabling medication management through health information technology (Health IT).

, 2011
K. Ann McKibbon, Cynthia Lokker, Steven M. Handler, Lisa Dolovich, Anne Holbrook, Daria O’Reilly, Robyn Tamblyn, Brian J Hemens, Runki Basu, Sue Troyan, Pavel S Roshanov, Norm Archer, Parminder Raina   +12 more
openalex   +1 more source

Diabetes medications with cardiovascular protection as we enter a new decade: can SGLT2 inhibitors, long-acting GLP-1 receptor agonists, pioglitazone and metformin complement each other to save lives?

, 2020
Robert E. J. Ryder, Ralph A. DeFronzo
openalex   +2 more sources

Medical Advertising amd Medical Reviewing [PDF]

BMJ, 1875
openaire   +2 more sources

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Improving medication error classification using a reasoning large language model. [PDF]

JAMIA Open
Krifors A, Beskow T, Jonsson M, Lindner KJ, Calås J, Arwsbo V, Sandström K, Norström C.   +7 more
europepmc   +1 more source

Pharmacists as clinical care partners: How a pharmacist-led intervention is associated with improved medication adherence in older adults with common chronic conditions [PDF]

Renae L. Smith-Ray, Liang Feng, Tanya Singh, K. Rudkin, Stacey Emmons, Erik Groves, Heather Kirkham   +6 more
openalex   +1 more source